Listen and follow our podcasts on:

Menarini Stemline Oncology

In this podcast series, Prof. Shaheenah Dawood and Assoc. Prof. Rena Callahan discuss oral SERDs for ER+/HER2- advanced or metastatic breast cancer.

 

Episode 1: Oral SERDs in ER+ breast cancer: efficacy, safety and treatment landscape

The experts explore the efficacy and safety profiles of oral SERDs and their place in the treatment landscape, and discuss how to optimise treatment selection and make appropriate sequencing decisions.

 

Episode 2: Oral SERDs in ER+ breast cancer: treatment selection and beyond

A deep-dive into two patient case studies of ER+/HER2- metastatic breast cancer, discussing the intricacies of treatment selection and sequencing to maximise outcomes, current data, and what to consider when adjusting dosage or switching treatments.

 

Episode 3: Oral SERDS in ER+ breast cancer: rare cases & treatment challenges

Prof. Dawood and Assoc. Prof. Callahan discuss the next two patient case studies of ER+/HER2- metastatic breast cancer, each presenting unique and rare situations that shed a light on the challenges confronting healthcare professionals and patients alike.

 

Shaheenah Dawood is a Consultant medical oncologist and professor in clinical oncology in the United Arab Emirates. She trained in medical oncology at McGill University Hospitals in Canada and subspecialized in breast cancer management at MD Anderson Cancer Center. During her training she was awarded multiple scholar in training awards and ASCO merit awards. She has served as an editorial fellow at the New England Journal of medicine and has an MPH from the Harvard School of Public Health. She has over 100 papers to her credit including 50 peer review original articles, 30 review articles and 12 book chapters. She serves as a reviewer for multiple journals. She currently leads the oncology clinical trials program at Mediclinic City Hospital Dubai. She also serves as president of the Excellence in oncology summit that is held annually in Dubai and is co president of the Asia pacific breast cancer summit (ABCS) and Asia pacific gastrointestinal cancer summit (APGCS). She has also recently launched the international BRCA forum and young womens forum.

Prof. Shaheenah Dawood has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

MSD, Roche, BMS, New Bridge, Novartis, llilly , Pfizer, Caris, Merck, Jaansen, Ipsen,Astrazeneca, Zulleg Pharma

Rena D. Callahan, MD, is Associate Clinical Professor of Health Sciences in the Division of Hematology-Oncology in the Department of Medicine at the University of Los Angeles, California (UCLA) David Geffen School of Medicine. She received her undergraduate degree from Yale University, and her medical degree from the University of Pennsylvania in Philadelphia, before completing an internship and residency in Internal Medicine and a fellowship in Hematology-Oncology at UCLA. Dr Callahan is board-certified in Internal Medicine, Medical Oncology, and Hematology. Dr Callahan is a member of the American Society of Clinical Oncology, the American Society of Hematology, and the American College of Physicians. She has served as principal or sub-investigator for numerous clinical research trials exploring topics related to breast cancer. Dr Callahan is a frequent lecturer on a variety of breast cancer topics and is focused on providing patient centered clinical care in the context of a large clinical practice.

Assoc. Clinical Professor Rena Callahan has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Support provided as a speaker from: Gilead, Lilly, Stemline, Seagen

Programme summary
Listen to the podcast now
Other episodes of this series
Oral SERDs in ER+ Breast Cancer – Episode 1

Oral SERDs in ER+ Breast Cancer – Episode 1

Oral SERDs in ER+ breast cancer: efficacy, safety and treatment landscape

Oral SERDs in ER+ Breast Cancer – Episode 2

Oral SERDs in ER+ Breast Cancer – Episode 2

Oral SERDs in ER+ breast cancer: treatment selection and beyond

Current Episode
Oral SERDs in ER+ Breast Cancer – Episode 3

Oral SERDs in ER+ Breast Cancer – Episode 3

Oral SERDs in ER+ breast cancer: rare cases & treatment challenges

Share this programme
This educational programme is supported by an Independent Educational Grant from Menarini Stemline Oncology
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from Menarini Stemline Oncology
Endorsement
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
BREAST CANCER CONNECT

BREAST CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Menarini Stemline Oncology.

Meet the experts Independent IME approved

Other programmes of interest

podcast Podcast

Episode

of

episode
  • clock 19 MIN
  • calendar Jul 2024

this xxx bayer
conference-update Conference update
Oncology 
ASCO 2024 highlights

Experts
Prof. Shaheenah Dawood
Endorsed by
Bayer
  • download Downloadable
    Resources
  • clock 03 MIN
  • calendar Jul 2024

podcast Podcast
Hemostasis and bleeding disorders Oncology 
Cancer and Thrombosis

A podcast discussion on treating thrombosis in patients with cancer

Experts
Prof. Dimitrios Tsakiris, Dr Lars Asmis
  • download Downloadable
    Resources
  • clock 14 MIN
  • calendar Sep 2023

Brought to you by COR2ED Medical Affairs in collaboration with Viatris.
Oncology 
Oral SERDs: New Endocrine Therapy Options in ER+ Advanced or Metastatic Breast Cancer

An interactive patient case video series from breast cancer specialists

Experts
Dr Elisa Agostinetto, Prof. Valentina Guarneri
Endorsed by
GRASP
  • clock 15 MIN
  • calendar Sep 2023

Educational programme supported by an Independent Educational Grant from Menarini Stemline Oncology
publication Publication
Oncology  Patient Support
Surveillance and Diagnosis of HCC in Asia: Poster Presentation at ILCA 2023

Data from an Asia-Pacific patient and HCP survey

Experts
Prof. Chee-Kiat Tan
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Sep 2023

Educational programme supported by an Independent Educational Grant from Roche.
video Video
Oncology 
Long-term Response in Advanced Colorectal Cancer

A video update from Prof. Gerald Prager

Experts
Assoc. Prof. Gerald Prager
  • download Downloadable
    Resources
  • clock 4 MIN
  • calendar Sep 2023

Educational programme supported by an Independent Educational Grant from Bayer.